Is David Ortiz a Hall of Famer?


BOSTON — A lot of people are going to be asking that question this morning. Anyone answering “no” had better bring a good argument, because they’re on the much tougher side of the battle today than they were a year ago.

First, though, let us set aside the World Series and look at Ortiz’s overall case. Don’t worry: we’ll get there in a minute.

The Numbers

David Ortiz is a career .287/.381/.549 hitter. He has 431 homers and 1429 RBI. His OPS is .930 and his OPS+ — which adjusts him to the level of his competition, his era and the ballparks in which he hits — is 139, which means (for quick and dirty purposes) that’s he’s 39% above the average hitter.  These numbers place Ortiz comfortably within the range of current Hall of Famers. Is he inner-circle? Not really, but his not borderline on the numbers either. There are many worse hitters than Ortiz in Cooperstown whose primary argument for induction was their offensive output.

The Designated Hitter Factor

Of course Ortiz is offensive output and offensive output alone.  He has played a mere 263 of his 1514 career games in the field, spending the rest of his time as a designated hitter.  Not having any defensive value does take away from his overall value, but the notion that just because one has zero defensive value means one has no Hall of Fame case is silly. The DH has been part of the game for 41 seasons. It is not some novelty anymore. Relief pitchers are routinely inducted to the Hall of Fame now and they are specialists too. Many — specifically, one-inning closers — are the sorts of specialists that have only existed since the 1980s, really. If no one knocks them for not being all-around players no one should knock the DH.  And the fact is that, with the possible exception of Edgar Martinez, David Ortiz has been the greatest DH in baseball history. And for what it’s worth, Martinez should be in the Hall too.

The Playoffs Factor

I don’t necessarily believe that there are clutch hitters. Meaning, guys who can be predicted to do well in tough spots and on big stages before the fact. But there is no escaping the fact that Ortiz has done well in tough spots and on big stages throughout his entire career.

In three World Series he has hit a mind-boggling .455/.576/.795 with 14 RBI in 14 games.  Is he some freak of nature in this regard? Not really, as his career playoff line — including division series and league championship series — is almost identical to his batting line since he joined the Boston Red Sox. But that’s not to diminish his playoff performance. We notice what he does in the playoffs far more and are usually amazed. The fact that he has basically done that for his entire Red Sox career and some people think he is undeserving of the Hall tells us that we are underrating his regular season performance.

The Performance Enhancing Drugs Factor

The ultimate objection to Ortiz’s candidacy will be that he was once associated with performance enhancing drugs. Specifically, his name was leaked — but never confirmed — as one of the 103 players who tested positive for banned substances during baseball’s trial drug testing in 2003. Drug testing that (a) was, by design, not to result in discipline; and (b) was supposed to remain anonymous but which had its anonymity compromised by over-zealous federal investigators.

You may have a personal rule that, if someone who took PEDs, they should not be in the Hall of Fame.  We’ve handled these arguments here several times before and have shown them to often be disingenuous and unfair. Maybe nothing will change your mind, but know that there are already Hall of Famers who took PEDs and know that the accusations made against Ortiz are perhaps the thinnest that have been lodged against any player. And know that, in the past decade, he has never tested positive for PEDs.

So: He’s a Hall of Famer, Right?

You bet your bippy he is. The numbers certainly bear this out. And he still has a lot of gas left in the tank so he’ll be providing value for a few years yet, adding to his case.  But you can be statistically illiterate and see this guy’s value as a player. His mark on the game is indelible. Numbers aside, Ortiz has killed it in the World Series. He clearly carried the Red Sox this year. He is clearly the leader of one of the best teams of his era.

When I have a tough call on a Hall of Fame candidate, I ask myself: “Can you tell the story of baseball in the era in which he played without including him?”  If the answer is no, it’s hard to argue against his Hall of Fame case.  And in Ortiz’s case, that answer is clearly no. The man should go to Cooperstown the first year he’s eligible.

2018 Preview: New York Mets

Rich Schultz/Getty Images
Leave a comment

Between now and Opening Day, HardballTalk will take a look at each of baseball’s 30 teams, asking the key questions, the not-so-key questions, and generally breaking down their chances for the 2018 season. Next up: The New York Mets.

Things couldn’t have gone much worse for the Mets in 2017, so the fact that they won 70 games is actually remarkable. Their hailed rotation was a shambles, as Noah Syndergaard made only seven starts. Zack Wheeler put up a 5.21 ERA over 17 starts; Matt Harvey was even worse with a 6.70 ERA across 18 starts and one relief appearance. Steven Matz compiled a 6.08 ERA in 13 starts. Just about the only consistency the club had came from Jacob deGrom, who finished with a career-high 3.53 ERA in 31 starts.

The rotation, as of right now, is healthy, save for deGrom, who has been battling a minor back issue during this spring. But so far, so good for everyone else. Well, there was Jason Vargas, who signed a two-year, $16 million deal with the Mets last month and suffered a non-displaced fracture of the hamate bone in his non-throwing hand. He underwent surgery and is expected to return shortly after the start of the regular season. But I mean, at least they still have everyone else!

Well, Michael Conforto is still recovering from shoulder surgery last September. The Mets are targeting May 1 for his return. That’s everyone, right? Wright? Where’s David Wright? The third baseman underwent two surgeries in September and October last year for his shoulder and back and still isn’t feeling well enough to play baseball, so the Mets shut him down for eight weeks.

The Mets haven’t had a legitimate full-time third baseman since 2014, Wright’s last full season. No Mets third baseman has played more than 55 games in a season at third base in the last three seasons. So the club went out and signed Todd Frazier to a two-year, $17 million contract. Frazier split last season with the White Sox and Yankees, hitting a combined .213/.344/.428 with 27 home runs and 76 RBI. While Frazier is now 32 years old and has seen a decline in power, he did set a career-high in walk rate last year at 14.4 percent and he’s still a solid defender. Frazier is still more than a capable player and he’ll look like a Greek god at the hot corner compared to what the Mets have trotted out there lately.

Shortstop at Citi Field now belongs to 22-year-old Amed Rosario. Among the top prospects in baseball, Rosario struggled last year, batting .248/.271/.394 across 46 games. Rosario has the most upside of any position player on the Mets’ roster, so his success will play a rather large factor in the team’s success this year. He can be a doubles and triples machine and a big threat on the bases if he gets his feet underneath him against big league competition.

Asdrubal Cabrera will handle second base. He’s been, quietly, quite good for the Mets over the last two seasons, offering a solid offensive approach along with his versatility – he played second and third base as well as shortstop last season. Now 32 years old, Cabrera hit .280/.351/.434 with 14 home runs and 59 RBI last season, which is more than enough when manning a position in the middle of the infield.

At first base, the Mets were able to pluck Adrian Gonzalez off the free agent wire. Gonzalez had gone to the Braves in the Matt Kemp trade, but the Braves quickly dropped him. The 35-year-old had a nightmarish 2017, compiling a .642 OPS in 71 games as he was bothered by back issues throughout the year. He became overshadowed in Los Angeles by Cody Bellinger, who won the NL Rookie of the Year Award, so the Dodgers had no reason to keep him around. Dominic Smith had been another first base option but he suffered a quad injury early in spring training and likely won’t be ready by Opening Day.

Travis d’Arnaud will get the lion’s share of starts behind the plate, backed up by Kevin Plawecki. d’Arnaud provides power, which is always nice to have from a catcher, but he doesn’t hit for average or draw walks, so his batting average and on-base percentage are underwhelming. And while d’Arnaud hasn’t been anything to write home about stopping the running game, he’s regarded as a good pitch framer.

In left field will stand the Mets’ biggest offensive threat, Yoenis Cespedes. Sadly, the slugger was limited to 81 games last year as he battled various leg injuries. When he was in the lineup, he hit .292/.352/.540 with 17 home runs and 42 RBI in 321 plate appearances. Among hitters who have taken at least 1,000 plate appearances since the start of the 2015 season, only 21 have put up a higher weighted on-base average than Cespedes (.368), who finds himself just ahead of Carlos Correa and just behind Corey Seager on that list.

Juan Lagares and Brandon Nimmo will share center field for the time being. Nimmo is having a big spring, putting up a .283/.361/.585 line with eight extra-base hits and 10 RBI in 61 spring plate appearances. He’s likely to bat leadoff against right-handed starters. Lagares isn’t having nearly as good a spring (.483 OPS) but will be in the lineup against lefties and will provide value with his Gold Glove-caliber defense. It’s also quite possible the Mets will trade him as they have gotten some interest lately.

Jay Bruce returns to right field after inking a three-year, $39 million contract in January. The slugger put up a solid .254/.324/.508 line last year between the Mets and Indians with 36 home runs and 101 RBI. Though he struggled – for the most part — in his first go-around with the Mets in the second half of 2016, he’s good for at least 25 home runs and 90 RBI if he can stay healthy, which the soon-to-be 31-year-old has been able to do in recent years.

New manager Mickey Callaway says he plans to use a closer-by-committee which will include Jeurys Familia, Jerry Blevins, A.J. Ramos and Anthony Swarzak. It’s a committee that could certainly have success, but Familia and Ramos are both coming off of down years and Swarzak has been slowed in spring training by a calf injury. The Mets will also have Paul Sewald, Hansel Robles, Rafael Montero, Seth Lugo, and Robert Gsellman providing help from the ‘pen. Wheeler could as well if the Mets determine he can provide more in a relief role than in a starting role.

With all their warts, the Mets do have a competitive roster. The starting rotation has the potential to be really good, led by a now-healthy Syndergaard and followed by deGrom. The offense should be a buoy in the midst of all of the other displeasing variance the Mets will likely wade through during the season. The bullpen won’t be world-beating but will likely not be a serious source of concern given their options. FanGraphs is projecting the Mets to win 82 games while PECOTA has them at 81, which means they’ll be in the mix for the NL Wild Card. That sounds about right to me, but ultimately I think they’ll fall just a bit short of .500.

Prediction: 79-83, third place in NL East.